Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, October 2008, p. 3814-3816, Vol. 52, No. 10
0066-4804/08/$08.00+0 doi:10.1128/AAC.00877-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Center for Research in Anti-Infectives and Biotechnology, Department of Medical Microbiology and Immunology,1 Creighton University Medical Center, Department of Pathology, Creighton University School of Medicine, Omaha, Nebraska2
Received 2 July 2008/ Accepted 17 July 2008
β-Lactamases produced by urine isolates from patients in long-term care facilities (LTCFs), outpatient, clinics, and one hospital in a U.S. community were characterized. A total of 1.3% of all Escherichia coli and Klebsiella pneumoniae isolates collected from patients in 30 LTCFs and various outpatient clinics produced extended-spectrum β-lactamases (ESBLs) and/or imported AmpC β-lactamases.
Published ahead of print on 28 July 2008.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»